Key result
Periodontal therapy improves endothelial function, lowers inflammation, and slows cIMT progression by ~0.02 mm.
Why the study?
Periodontitis is associated with systemic inflammation, endothelial dysfunction, and cardiovascular disorders, and whether periodontal therapy improves blood pressure and vascular function remains an important clinical question.
Does periodontal therapy improve blood pressure and vascular function in patients with periodontitis?
Does periodontal therapy improve blood pressure and vascular function in patients with periodontitis?
Periodontal therapy consistently reduces systemic inflammation and improves endothelial function, supporting its role as an adjunctive strategy in cardiovascular risk management, though its heterogeneous effects on blood pressure mean it cannot replace antihypertensive therapy.
Answers are grounded in this paper and cite their sources.
Periodontal therapy may improve endothelial function and slow cIMT progression; leaves open blood pressure effects and clinical adoption.
Introduction: Periodontitis is a chronic inflammatory disease associated with an increased systemic inflammatory burden, endothelial dysfunction, and cardiovascular disorders. Whether periodontal therapy can improve blood pressure (BP) and vascular function remains an important clinical question. Objective: This narrative review summarizes current evidence (2022–2025) on the effects of periodontal therapy on BP, endothelial function, arterial stiffness and structure, and inflammatory biomarkers. Methodology: Nine relevant publications comprising randomized controlled trials, systematic reviews, and meta-analyses were narratively synthesized. Results: Periodontal therapy, particularly intensive therapy, consistently reduced inflammatory biomarkers such as C-reactive protein (CRP) and interleukin-6, and tended to improve endothelial function as measured by flow-mediated dilation (FMD). Effects on BP were heterogeneous: some meta-analyses reported reductions in systolic blood pressure, whereas a two-year randomized trial found no significant differences in BP. Recent studies also demonstrated a deceleration in the progression of carotid intima-media thickness, but no improvement in pulse wave velocity. Conclusion: Periodontal therapy has the potential to serve as an adjunctive approach in managing cardiovascular risk, but it cannot yet be considered a substitute for antihypertensive therapy. Well-powered randomized controlled trials with BP as a primary outcome are still needed.
No takes yet. Share an insight, caveat, or question.
Fierdiansyah et al. (2026) conducted a review in Periodontitis. Periodontal therapy (intensive or non-surgical) vs. Control periodontal therapy or standard care was evaluated on Blood pressure, endothelial function (FMD), arterial stiffness/structure (PWV, cIMT), and inflammatory biomarkers (CRP, IL-6). Periodontal therapy consistently reduced CRP and IL-6, improved FMD, and slowed cIMT progression, while effects on blood pressure were heterogeneous and PWV was unchanged.
Synapse has enriched 10 related papers. Consider them for comparative context: